股市必读:九安医疗(002432)预计2025年全年扣非后净利润盈利20.7亿元至24亿元

Core Viewpoint - Jiuan Medical (002432) is expected to report significant growth in net profit for the year 2025, driven by strong performance in asset management and stable demand for medical products [1][3]. Trading Information Summary - On January 26, Jiuan Medical closed at 42.71 yuan, up 0.78%, with a turnover rate of 3.1%, trading volume of 136,100 shares, and a transaction value of 577 million yuan [1]. - The net outflow of main funds was 4.0722 million yuan, while speculative funds saw a net inflow of 12.6775 million yuan, and retail investors experienced a net outflow of 8.6052 million yuan [1][3]. Performance Disclosure Highlights - Jiuan Medical forecasts a net profit attributable to shareholders for 2025 between 202 million yuan and 235 million yuan, representing a year-on-year growth of 21.05% to 40.83% [1]. - The expected net profit after deducting non-recurring gains and losses is projected to be between 207 million yuan and 240 million yuan, with a year-on-year increase of 23.18% to 42.81% [1][3]. - The basic earnings per share are anticipated to be between 4.6782 yuan and 5.4424 yuan [1][3]. Company Announcement Summary - Jiuan Medical has communicated its 2025 performance forecast with its accounting firm, and there are no discrepancies reported [1][3].

ANDON HEALTH-股市必读:九安医疗(002432)预计2025年全年扣非后净利润盈利20.7亿元至24亿元 - Reportify